A novel peptide RIFV suppresses human adipocyte differentiation through the inhibition of C/EBP-β expression

BACKGROUND: Obesity is a global epidemic disease that increases the risk of metabolic syndrome. However, therapeutic drugs for obesity are still scarce. In recent years, peptides have been identified as new biological regulators. RIFV (R-I-F-V-P-I-K-G-R-P-A-P), a novel active peptide from our peptid...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Nutr Metab (Lond)
Päätekijät: Zhang, Wen, Shen, Dan, Li, Yun, Zhong, Hong, Wang, Xing, Cui, Xian-wei, Shi, Chun-Mei, Ji, Chen-Bo, Guo, Xi-Rong, Chen, Ling
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2019
Aiheet:
Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6929371/
https://ncbi.nlm.nih.gov/pubmed/31889968
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12986-019-0414-z
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia